country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-177110

Copy Link Print Information

(+)-KF15232

(+)-KF15232 is a phosphodiesterase III/V inhibitor. (+)-KF15232 inhibits cAMP hydrolysis. (+)-KF15232 acts as a myofibrillar Ca²⁺ sensitizer. (+)-KF15232 can be used in research related to cardiovascular diseases.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 174232-20-3
Formel: C₂₀H₁₉N₅O
Molecular Weight:345.41

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

(+)-KF15232 Chemical Structure

CAS. Nr.: 174232-20-3

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- In Vitro
- In Vivo
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

IC₅₀ & Target

^[1]

PDE Ⅲ

PDE Ⅱ

Alle Phosphodiesterase (PDE) Isoform-spezifische Produkte anzeigen :

In Vitro

Local Vascular RegulationRegulation of Cardiac Pump FunctionOthers

Local Vascular Regulation

(+)-KF15232 relaxes guinea pig aortic rings precontracted with 10 µM PHE in a concentration-dependent manner^[1].

Regulation of Cardiac Pump Function

(+)-KF15232 ((+)-1) (1-100 μM) exhibits the strongest myofibrillar Ca²⁺ sensitizing activity among the tested compounds in skinned guinea pig papillary muscle fibers^[1].

Others

(+)-KF15232 (10-30 min) inhibits bovine arterial PDE III and PDE V with IC₅₀ values of 300 and 1000 nM, respectively, but does not inhibit canine cardiac PDE III at a concentration of 1000 nM, and also has no inhibitory effect on bovine arterial PDE IV (>10000 nM)^[1].
(+)-KF15232 produces a concentration-dependent positive inotropic response in isolated guinea pig papillary muscles^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Regulation of Cardiac Pump FunctionCardiovascular Regulation

Regulation of Cardiac Pump Function

Cardiovascular Regulation

(+)-KF15232 (0.01-1.0 mg/kg; i.v.; increasing doses at 5-min intervals) produces a dose-dependent positive inotropic effect in anesthetized guinea pigs^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Hartley (Male, 460-570 g)^[1]
Dosage:

0.01; 0.1; 1 mg/kg
Administration:

i.v.; increasing doses at 5-min intervals
Result:

Produced a dose-dependent increase in LV dP/dtmax at 0.01-1.0 mg/kg i.v.
Heart rate increased by less than 16% even at the maximum dose.

Related Protocols :

Ca²⁺ Staining Technique

Chemical Information

CAS. Nr. 174232-20-3
Molecular Weight 345.41
Formel C₂₀H₁₉N₅O
SMILES

N(CC1=CC=CC=C1)C=2C3=C(C=C(C=C3)C=4[C@@H](C)CC(=O)NN4)N=CN2
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Handling Instructions (2659 KB)

Verweise

[1]. Nomoto Y, et al. Studies of cardiotonic agents. 8. Synthesis and biological activities of optically active 6-(4-(benzylamino)-7-quinazolinyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone (KF15232). J Med Chem. 1996 Jan 5;39(1):297-303.

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen